Cargando…
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504382/ https://www.ncbi.nlm.nih.gov/pubmed/34380893 http://dx.doi.org/10.4103/1673-5374.320985 |
| _version_ | 1784581311291195392 |
|---|---|
| author | D'Amico, Emanuele Zanghì, Aurora Avolio, Carlo |
| author_facet | D'Amico, Emanuele Zanghì, Aurora Avolio, Carlo |
| author_sort | D'Amico, Emanuele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8504382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85043822021-11-01 Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies D'Amico, Emanuele Zanghì, Aurora Avolio, Carlo Neural Regen Res Perspective Wolters Kluwer - Medknow 2021-08-04 /pmc/articles/PMC8504382/ /pubmed/34380893 http://dx.doi.org/10.4103/1673-5374.320985 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Perspective D'Amico, Emanuele Zanghì, Aurora Avolio, Carlo Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title | Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title_full | Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title_fullStr | Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title_full_unstemmed | Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title_short | Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| title_sort | injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504382/ https://www.ncbi.nlm.nih.gov/pubmed/34380893 http://dx.doi.org/10.4103/1673-5374.320985 |
| work_keys_str_mv | AT damicoemanuele injectableversusoralfirstlinemultiplesclerosistherapiesknowsandunknownsfromobservationalstudies AT zanghiaurora injectableversusoralfirstlinemultiplesclerosistherapiesknowsandunknownsfromobservationalstudies AT avoliocarlo injectableversusoralfirstlinemultiplesclerosistherapiesknowsandunknownsfromobservationalstudies |